Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar September 10, 2025 Encaleret is an investigational drug. Its safety and efficacy have not been fully evaluated by any regulatory authority. Alexis and Jackson Living with ADH1 Forward-Looking Statements and Disclaimer Statements in this Presentation that are not statements of historical fact are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exc ...